WHO Presentation Outlines Diagnostic and Countermeasure Gaps for Bundibugyo Virus Disease in Uganda (cdn.who.int)

• Bundibugyo virus is >30% genetically distinct from other ebolaviruses, requiring species-specific diagnostics.
• No approved vaccines or treatments exist for BDBV; supportive care is key while countermeasure research is prepared.
• Current outbreak involves cross-border transmission between DRC and Uganda, with health facility exposures and community deaths needing urgent IPC.

"A WHO presentation from May 26, 2026, reviews the 2007 discovery of Bundibugyo virus (BDBV) and its implications for the current outbreak. The slide deck emphasizes that BDBV is genetically distinct from other ebolaviruses, requiring broad screening, BDBV-specific PCR, and sequencing for accurate detection. No approved vaccines or treatments exist specifically for BDBV; supportive care remains central. The presentation highlights the need for rapid case confirmation, IPC measures, contact tracing, and research readiness. It serves as a practical playbook for the ongoing response."